You have 9 free searches left this month | for more free features.

City

Wuhan (2)

Beijing (1)

Shanghai (1)

Condition

Hepatitis B, Chronic (1)

Hepatitis b & Liver Dysfunction (1)

Pharmacokinetics of Hydronidone (1)

Overall Status

Completed (3)

Sign in for free

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Beijing Continent Pharmaceutical Co, Ltd. (2)

Shanghai Genomics, Inc. (1)

Collaborator

Intervention

hydronidone (3)

entecavir (1)

placebo (1)

Study Documents

Intervention Type

drug (3)

Funder Type

Industry (3)

Study Type

Interventional (3)

hydronidone

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Hepatitis B, Chronic Trial in Shanghai, Beijing (Hydronidone, Placebo, Entecavir)

Completed

Hepatitis B, Chronic

Hydronidone
+2 more

Shanghai, Shanghai, China
+1 more

Jun 21, 2022

Pharmacokinetics of Hydronidone Trial in Wuhan (Hydronidone)

Completed

Pharmacokinetics of Hydronidone

Hydronidone

Wuhan, Hubei, China

Ethics committee of drug clinical trials of huazhong university

Mar 23, 2021

Hepatitis b & Liver Dysfunction Trial in Wuhan (Hydronidone)

Completed

Hepatitis b & Liver Dysfunction

Hydronidone

Wuhan, Hubei, China

Medical ethics committee of wuhan infectious disease hospital

Mar 23, 2021